Is the potent 5-HT1A receptor agonist, alnespirone (S-20499), affecting dopaminergic systems in the rat brain?
- 1 June 1998
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 350 (2-3) , 171-180
- https://doi.org/10.1016/s0014-2999(98)00254-4
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The effect of the selective 5‐HT1A agonists alnespirone (S‐20499) and 8‐OH‐DPAT on extracellular 5‐hydroxytryptamine in different regions of rat brainBritish Journal of Pharmacology, 1997
- Differential Effects of Ipsapirone on 5‐Hydroxytryptamine Release in the Dorsal and Median Raphe Neuronal PathwaysJournal of Neurochemistry, 1996
- Synaptic Regulation of Mesocorticolimbic Dopamine NeuronsAnnual Review of Neuroscience, 1996
- Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: Microdialysis studies in the awake and anaesthetized ratNeuropharmacology, 1994
- 5-HT1A Partial AgonistsDrugs, 1991
- The concept of selectivity in 5-HT receptor researchEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brainTrends in Pharmacological Sciences, 1989
- 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activityJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982
- 8-Hydroxy-2-(dipropylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonistJournal of Medicinal Chemistry, 1981
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966